APA (7th ed.) Citation

P, X., X, Z., L, W., K, L., Y, L., M, Z., . . . Y, H. (2026). Predictive values of baseline 18F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapy. Bone marrow transplantation, 61(3), 312. https://doi.org/10.1038/s41409-025-02769-x

Chicago Style (17th ed.) Citation

P, Xiao, et al. "Predictive Values of Baseline 18F-FDG PET/CT for Toxicities and Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Following BCMA CAR T-cell Therapy." Bone Marrow Transplantation 61, no. 3 (2026): 312. https://doi.org/10.1038/s41409-025-02769-x.

MLA (9th ed.) Citation

P, Xiao, et al. "Predictive Values of Baseline 18F-FDG PET/CT for Toxicities and Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Following BCMA CAR T-cell Therapy." Bone Marrow Transplantation, vol. 61, no. 3, 2026, p. 312, https://doi.org/10.1038/s41409-025-02769-x.